We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$34.9B
AUM Growth
+$6.68B
(+24%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,971
New
955
Increased
1,167
Reduced
1,145
Closed
694
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.11% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Financials | 9.06% |
| 4 | Healthcare | 8.71% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
2276
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $685K | ﹤0.01% |
6,742
-32,264
| -83% | -$2.99M |
|
2277
CALL
Colgate-Palmolive
CL
$74.4B
| $684K | ﹤0.01% |
8,000
-1,000
| -11% | -$82.7K |
|
2278
CALL
Revolve Group
RVLV
$1.73B
| $683K | ﹤0.01% |
+21,900
| New | +$488K |
|
|
SIC
2279
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $683K | ﹤0.01% |
95,512
+54,649
| +134% | +$396K |
|
2280
Navios Maritime Partners
NMM
$2.26B
| $682K | ﹤0.01% |
+60,881
| New | +$454K |
|
2281
Korn Ferry
KFY
$4.28B
| $681K | ﹤0.01% |
15,652
-106,503
| -87% | -$3.92M |
|
2282
Lesaka Technologies
LSAK
$420M
| $681K | ﹤0.01% |
+138,328
| New | +$484K |
|
2283
PUT
T. Rowe Price
TROW
$24.3B
| $681K | ﹤0.01% |
+4,500
| New | +$644K |
|
|
ABMD
2284
PUT
DELISTED
Abiomed Inc
ABMD
| $681K | ﹤0.01% |
2,100
-6,900
| -77% | -$1.91M |
|
2285
PUT
Stratasys
SSYS
$774M
| $680K | ﹤0.01% |
32,800
+17,200
| +110% | +$276K |
|
2286
CALL
Zillow
ZG
$7.63B
| $680K | ﹤0.01% |
5,000
-200
| -4% | -$22.5K |
|
|
CTT
2287
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $680K | ﹤0.01% |
72,637
+29,191
| +67% | +$266K |
|
2288
PUT
MGM Resorts International
MGM
$11.2B
| $677K | ﹤0.01% |
21,500
-64,800
| -75% | -$1.67M |
|
2289
PUT
ScottsMiracle-Gro
SMG
$3.66B
| $677K | ﹤0.01% |
3,400
+200
| +6% | +$34.3K |
|
|
CVET
2290
DELISTED
Covetrus, Inc. Common Stock
CVET
| $677K | ﹤0.01% |
23,539
-96,815
| -80% | -$2.61M |
|
|
AMED
2291
PUT
DELISTED
Amedisys
AMED
| $675K | ﹤0.01% |
2,300
+1,300
| +130% | +$333K |
|
2292
PUT
EQT Corp
EQT
$32.3B
| $675K | ﹤0.01% |
+53,100
| New | +$765K |
|
2293
Penske Automotive Group
PAG
$14.2B
| $674K | ﹤0.01% |
+11,353
| New | +$640K |
|
2294
CALL
American Tower
AMT
$80.4B
| $673K | ﹤0.01% |
3,000
-5,000
| -63% | -$1.16M |
|
|
ATVI
2295
DELISTED
Activision Blizzard
ATVI
| $672K | ﹤0.01% |
+7,236
| New | +$588K |
|
2296
Skywest
SKYW
$4.34B
| $670K | ﹤0.01% |
16,614
-9,827
| -37% | -$359K |
|
2297
CALL
Arista Networks
ANET
$238B
| $668K | ﹤0.01% |
36,800
+4,800
| +15% | +$76.1K |
|
2298
CALL
Wolfspeed
WOLF
$1.71B
| $667K | ﹤0.01% |
6,300
+1,300
| +26% | +$104K |
|
|
ONCS
2299
DELISTED
OncoSec Medical Incorporated
ONCS
| $665K | ﹤0.01% |
4,686
+2,116
| +82% | +$226K |
|
2300
Mustang Bio
MBIO
$4.55M
| $664K | ﹤0.01% |
234
-240
| -51% | -$574K |
|
Similar funds
VAM
Two Sigma Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Two Sigma Investments held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- Two Sigma Investments's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- Two Sigma Investments added most to NVIDIA in Q4 2020, an estimated $257M increase.
- Two Sigma Investments's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- Two Sigma Investments fully exited Pfizer in Q4 2020, selling an estimated $252M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- Two Sigma Investments opened 955 new positions and closed 694 in Q4 2020.
- Two Sigma Investments's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.